Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea

Trial Profile

Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Sep 2012

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine
  • Indications Pneumococcal infections
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms PCVFU
  • Most Recent Events

    • 29 May 2012 Actual patient number changed from 450 to 280 according to ClinicalTrials.gov. (Follow-up trial: NCT01414504)
    • 29 May 2012 Actual patient number changed from 450 to 280 according to ClinicalTrials.gov. (Follow-up trial: NCT01414504)
    • 10 Aug 2011 New source for the extension trial identified and integrated (NCT01414504).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top